Phase Ib multicenter study of anti-TIM-3 (S095018/Sym023) in combination with anti-PD-1 (Sym021) in patients with advanced/metastatic recurrent biliary tract cancer
一项针对晚期/转移性复发性胆道癌患者的Ib期多中心研究,评估抗TIM-3(S095018/Sym023)联合抗PD-1(Sym021)的疗效。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-012344
Ghiringhelli, Francois; Kim, Richard; Macarulla, Teresa; Moreno, Irene; Abdul Razak, Albiruni; Rodon Ahnert, Jordi; Liao, Chih-Yi; Davis, Sarah Lindsey; Mahipal, Amit; Marron, Thomas; Raimbourg, Judith; Kaplon, Hélène; Geronimi, Julia; Harouki, Najah; Rodrigues, Christelle; Darcel, Pauline; Jakobsen, Janus Schou; Skartved, Niels; Hald, Rikke; Lopez-Ravnborg, Daleen; He, Peng; Ianopoulos, Xenophon; Askoxylakis, Vasileios; Lakhani, Nehal